The future of infusion therapy is filled with promise. New therapies, evolving technologies, and renewed models of care continue to expand what’s possible for patients with chronic and complex conditions. Yet, Brian Nyquist, CEO of the National Infusion Center Association, opened the 2026 NICA Annual Conference with a powerful reminder: innovation alone isn’t enough. Progress also requires advocacy, collaboration, and a continued commitment to breaking down barriers that prevent patients from accessing the care they need.
One statement from the session resonated throughout the room:
“Different patients. Different diseases. Same negative outcome.”
While every patient’s diagnosis and journey are unique, many face the same obstacles to receiving timely, effective care. Financial barriers, insurance challenges, limited access to providers, and gaps in awareness or support can delay or even prevent treatment altogether. This is why advocacy remains a critical part of advancing healthcare.
By speaking up for patients, championing standards of excellence, and working together across the industry, healthcare leaders can help create a system where life-changing therapies are more accessible to those who need them most.
Why Timely Access to Infusion Therapy Matters:
From Reactive to Proactive Care
Healthcare discussions often focus on the immediate cost of treatment. While financial stewardship is important, it is equally important to consider the long-term impact of delaying or limiting access to care.
When patients cannot receive appropriate treatment at the right time, the consequences can extend far beyond the initial cost. Delayed care may contribute to disease progression, avoidable hospitalizations, emergency department visits, and more intensive interventions later. In many cases, these outcomes increase both the financial burden on the healthcare system and the personal burden on patients and their families.
By viewing healthcare through a long-term lens, organizations can better recognize the value of investing in timely, accessible care that supports improved outcomes and reduces preventable complications.
Nyquist also challenged attendees to rethink how healthcare is often delivered:
“We wait for people to get sick and treat them. We call that healthcare.”
This perspective highlights an opportunity for the infusion industry to continue moving toward a more proactive approach. Rather than reacting after a patient’s condition has significantly worsened, healthcare providers can focus on earlier intervention, ongoing disease management, and coordinated care that helps patients maintain their health before complications arise.
Infusion therapy plays an important role in this shift by helping many patients receive specialized treatments outside of the traditional hospital setting while supporting continuity of care.
Preserving Independence
Is a Meaningful Outcome
One of the most impactful themes of the session was the importance of preserving patient independence.
Success in healthcare isn’t measured solely by clinical outcomes or costs. It’s also reflected in a patient’s ability to continue living independently, spending time with loved ones, remaining active in their community, and maintaining their quality of life.
When patients have timely access to infusion therapy and the support they need, they may be able to avoid unnecessary hospitalizations, reduce the likelihood of certain surgeries or disease-related complications, and continue receiving care in environments that are often more comfortable and convenient.
These outcomes represent meaningful improvements not only for patients but also for caregivers and the broader healthcare system.
The Future of Infusion Starts with Access
The future of infusion therapy is filled with opportunity, but innovation alone isn’t enough. As Brian Nyquist’s keynote emphasized, meaningful progress depends on ensuring patients can access the therapies they need without unnecessary barriers or delays.
Improving access requires collaboration across the healthcare continuum. Providers, manufacturers, distributors, payers, and industry organizations all play a role in advancing quality, safety, and equitable care for the patients who depend on infusion therapy.
At Right Way Medical, we’re proud to support that mission by providing the products, services, and operational solutions that help infusion providers deliver exceptional patient care. As the industry continues to evolve, we’ll remain committed to helping providers improve efficiency, expand access, and achieve better patient outcomes.
Because innovation creates possibilities, but access transforms those possibilities into better care for every patient.
